Summary
For Year 2026-27, GPT Healthcare reports the following shareholding: Total Promoters at 65.57%, Mutual Fund at 4.69%, Insurance at 0.01%, Foreign Institutional Investors at 2.81%, Domestic Institutional Investors at 0.93%, and Retail at 25.98%. This breakdown provides a quick snapshot of ownership distribution for GPT Healthcare in 2026-27.
GPT Healthcare FAQs
As of 05-2026, the promoter shareholding in GPT Healthcare stands at 65.57% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of GPT Healthcare is 2.81% and 0.93% respectively.
The retail shareholding of the GPT Healthcare is 25.98%.
Changes in shareholding patterns of GPT Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of GPT Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
